Cyclomics
Epinn
Next generation Tumor classification
Rapid tumour classification to assist the pathologist during diagnosis, shortening the timeline from 1 week to <90 minutes! Which enables rapid decision-making for the clinicians, and even makes it possible to classify tumours during surgery.
Epinn enables AI-powered methylation analyses across ONT, Illumina, and bisulfite sequencing workflows.
Advantages of Epinn
Epinn allows you to run state-of-the-art tumor classification and copy number analysis, no advanced skills required. More advantages:
-
Local: no sample data leaves your machine. Giving you full control over your data.
-
Secure: Prioritizes data security.
-
Real-time: Get feedback about the classification at every single step of the process
-
Fast: Epinn runs multithreaded on your machine.
-
Accurate: Use the latests models with the highest accuracy.
-
Intuitive: User-friendly interface designed for ease of use.
Current models
More in the works
We are hard at work to expand!
Status:
Epinn-OSCC
Classifing oral squamous cell carcinoma samples based on methylation patterns.
Status:
Epinn-CNS
Our improved version of sturgeon to classifiy central nerveous system tumor biopsies.
Status:
Sturgeon
The original, Nature published, Metylation based predicition model.
.png)
